Aspen Aerogels Files 8-K on Financial Condition, Reg FD Disclosure

TL;DR

**Aspen Aerogels just dropped an 8-K with fresh financial deets, so check it out.**

AI Summary

Aspen Aerogels, Inc. filed an 8-K on January 11, 2024, to report on its results of operations and financial condition, as well as Regulation FD disclosure. This filing indicates that the company is providing current financial information, which is crucial for investors to understand its ongoing performance. For shareholders, this matters because it offers a timely glimpse into the company's health, potentially influencing stock valuation and future investment decisions.

Why It Matters

This filing provides investors with updated financial information, allowing them to assess Aspen Aerogels' current operational health and make informed decisions about their investment.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information and does not inherently present new risks, but rather provides data for risk assessment.

Analyst Insight

A smart investor would review the detailed financial information that will be subsequently released or referenced by this 8-K to understand Aspen Aerogels' current performance and any forward-looking statements, then adjust their investment thesis accordingly.

Key Players & Entities

• Aspen Aerogels, Inc. (company) — the registrant filing the 8-K
• January 11, 2024 (date) — the date of the earliest event reported and filing date
• 001-36481 (null) — Commission File Number for Aspen Aerogels, Inc.
• 04-3559972 (null) — IRS Employer Identification No. for Aspen Aerogels, Inc.
• 30 Forbes Road, Building B, Northborough, MA 01532 (null) — Address of Principal Executive Offices for Aspen Aerogels, Inc.
• (508) 691-1111 (null) — Telephone Number for Aspen Aerogels, Inc.
• ASPN (null) — Trading Symbol for Aspen Aerogels, Inc. Common Stock
• The New York Stock Exchange (null) — Exchange on which Aspen Aerogels, Inc. Common Stock is registered

FAQ

Filing Documents

• aspn-20240111.htm (8-K) — 46KB
• aspn-ex99_1.htm (EX-99.1) — 34KB
• 0000950170-24-003759.txt ( ) — 206KB
• aspn-20240111.xsd (EX-101.SCH) — 30KB
• aspn-20240111_htm.xml (XML) — 5KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On January 11, 2024, Aspen Aerogels, Inc. issued a press release containing recent developments with its business, preliminary financial information for full year and fourth quarter 2023, and a preliminary 2024 financial outlook. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the heading “Current 2024 Baseline Revenue Outlook” and under the heading “About Aspen Aerogels, Inc.,” together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The information set forth in the press release, together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Aspen Aerogels, Inc. on January 11, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K. The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Aspen Aerogels, Inc. Date: January 11, 2024 By: /s/ Ricardo C. Rodriguez Name: Ricardo C. Rodriguez Title: Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR